Melphalan plus prednisolone in the treatment of multiple myeloma

Authors

  • M Begum Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka
  • A Akther Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka
  • KH Khan Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka
  • MS Kaiser Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka
  • MJ Rahman Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka
  • MN Alam Department of Haematology, Bangabandhu Sheik Mujib Medical University, Dhaka

Keywords:

Multiple myeloma, myeloablative Agonists, prednisolone

Abstract

Mymensingh Med J. 2012 Jan;21(1):93-97

The abstract of this article is available on the PubMed website

Abstract
367

Published

2012-11-08

How to Cite

Begum, M., Akther, A., Khan, K., Kaiser, M., Rahman, M., & Alam, M. (2012). Melphalan plus prednisolone in the treatment of multiple myeloma. Mymensingh Medical Journal, 21(1), 93-97. https://doi.org/10.3329/mmj.v21i1.12518

Issue

Vol. 21 No. 1 (2012)

Section

Original Contributions

How to Cite

Begum, M., Akther, A., Khan, K., Kaiser, M., Rahman, M., & Alam, M. (2012). Melphalan plus prednisolone in the treatment of multiple myeloma. Mymensingh Medical Journal, 21(1), 93-97. https://doi.org/10.3329/mmj.v21i1.12518